The invention more particularly relates to novel recombinant human glycoproteins (rh glycoproteins), preferably novel rh differentiation factors, especially rh erythropoietin; novel rh growth factors, especially rh CSF (colony stimulating factor), rh GMCSF (granulocyte monocyte stimulation factor); novel rh thrombolytic agents, especially rh tPA (tissue plasminogen activator) and rh urokinase; novel rh thromboprophylactic agents, especially rh antithrombin III; novel rh coagulation factors, especially rh factor VIII and rh factor IX; novel rh interferons, especially rh $g(a), $g(b) and $g(g) interferons; and novel rh interleukins, especially rh IL-2, IL-15, IL-16 and IL-17.
Nach der Induktionsbehandlung beträgt die empfohlene Dosis # mg als subkutane Injektion jede zweite Wochepatents-wipo patents-wipo